Patents by Inventor Raymond H. DIEP

Raymond H. DIEP has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240148688
    Abstract: In alternative embodiments, provided are methods for treating and ameliorating a cancer, or recurrence of a cancer such as acute myeloid leukemia (AML) comprising administration to an individual in need thereof a pharmaceutical composition comprising 17S-FD-895 (or rebecsinib) and second drug such as an ATP-competitive protein tyrosine kinase inhibitor such as dasatinib. In alternative embodiments, provided are methods for the in vivo inhibition of myeloproliferative neoplasm (MPN) or AML stem cell propagation comprising administration to an individual in need thereof a pharmaceutical composition comprising 17S-FD-895 and second drug. In alternative embodiments, provided are methods for the in vivo inhibition pre-leukemia stem cell (pre-LSC) transformation into leukemia stem cells (LSCs) comprising administration to an individual in need thereof a pharmaceutical composition comprising 17S-FD-895 and second drug.
    Type: Application
    Filed: February 1, 2022
    Publication date: May 9, 2024
    Inventors: Catriona JAMIESON, Leslie CREWS ROBERTSON, Michael BURKART, Larisa BALAIAN, Phoebe MONDALA, Cayla MASON, Raymond H. DIEP, James LACLAIR, Thomas WHISENANT, Warren C. CHAN, Inge VAN DER WERF, Peggy WENTWORTH, Wenxue MA